A study to assess impact of GLT2 inhibitors on insulin clearance, body weight changes and metabolic disorders in Japanese men with type 2 diabetes mellitus
Latest Information Update: 23 Jul 2020
At a glance
- Drugs Tofogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- 23 Jul 2020 New trial record
- 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association